The X-Men '97 team isn’t done breaking hearts just yet. Speaking exclusively with Collider’s Maggie Lovitt at New York Comic Con, Marvel TV boss Brad Winderbaum shed new light on one of the show’s ...

If you're holding shares of Vertex Pharmaceuticals or thinking about adding some to your portfolio, you're not alone in wondering what the right move is. The stock's recent momentum may have caught ...

KING OF PRUSSIA, Pa., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX), a leading global technology provider of indirect tax solutions, today announced that it will release third quarter ...

Aircraft spark-ignition engines use dual magnetos and spark plugs for redundancy and increased power, with magnetos generating self-contained electricity for ignition. Pilots perform pre-flight ...

- Food and Drug Administration granted Breakthrough Therapy Designation for povetacicept in IgA nephropathy; on track to file for accelerated approval in the U.S. in H1 2026 if 36-week interim ...

Vertex has begun a full-court press for Journavx, enlisting NBA All-Star Jayson Tatum to discuss his use of the new non-opioid painkiller while recovering from a serious injury. Tatum ruptured his ...

Renowned SFX and makeup artist Gi Ponci recently posted a picture of an official Avengers: Doomsday merch that featured as many as 28 confirmed characters from the film. The image not only served as a ...

Last week, Microsoft released an important Windows 11 patch known as update KB5065426. Unfortunately, it didn’t take long for error reports to start pouring in from ...

Vertex Pharmaceuticals has a lot of buy and hold ratings, but there aren't any sell ratings from Wall Street analysts. Around 75,000 people with cystic fibrosis rely on Vertex Pharmaceuticals to keep ...

After three months of beta testing, Apple is finally releasing iOS 26 to iPhone users today. Going by past years' trends, the update should be available around 1 PM ET, along with the official ...

The recent Vertex Pharmaceuticals Incorporated stock drop after VX-993 trial results is overblown; the pain franchise remains robust with multiple promising avenues and ongoing trials. Vertex's CF ...

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) reported better-than-expected earnings for the second quarter after the market close on Monday. The company's revenue came in at $2.97 billion versus estimates ...